由花粉引起的喘:诊断和治疗含义
L Cecchi1, A Musarra2, K Jaubashi3
1Allergy and Immunology Unit, San Giovanni di Dio Hospital, USL Tsocana centro, Florence, Italy.
European annals of allergy and clinical immunology
|September 2, 2025
概括
由于花粉引起的喘是一种独特的表型. 提出一种新的诊断方案和风险分层治疗算法, 以有效地管理花粉过敏喘.
科学领域:
- 过敏和免疫学
- 呼吸系统医学
- 临床医学
背景情况:
- 由花粉引起的喘被认为是一种具有独特临床特征的特定喘表型.
- 在花粉季和无症状期之间,诊断和症状严重程度有显著的波动.
- 暴露于花粉是导致喘症状和恶化的主要原因.
研究的目的:
- 推出一种新的诊断方案,
- 为量身定制的治疗策略制定风险分层模型.
- 提供基于证据的治疗算法来控制由花粉引起的喘.
主要方法:
- 开发一种新型的花粉诱导喘诊断方案.
- 实施风险分层模型,包括患者病史和客观标志物.
- 基于风险评估的治疗算法的建议.
主要成果:
- 一个新的诊断方法已经建立了花粉诱导的喘.
- 风险分层模型使个性化治疗选择成为可能.
- 拟议的算法有助于量身定制的管理策略.
结论:
- 需要特殊的诊断和治疗方法.
- 风险分层对于优化治疗干预至关重要.
- 开发的方案和算法支持针对花粉引起的喘患者的个性化护理.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
575
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
575


